We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
RNA Disease Diagnostics (RNADD) has received an exclusive global licence from the University of Maryland, Baltimore (UMB) and the University of Maryland, Baltimore County (UMBC) for an advanced
Health technology company Royal Philips has entered into an agreement with the 28-hospital Dutch SAZ (Association of Collaborating General Hospitals) group for connected care solutions. Under the deal,
Genomic diagnostics company Veracyte has agreed to acquire US-based commercial-stage precision oncology company Decipher Biosciences in a deal valued at around $600m. The deal includes $250m in cash
Bioelectric medicine company Pulse Biosciences has secured approval from the US Food and Drug Administration (FDA) for its CellFX system. The CellFX system has been approved for dermatologic
Diagnostic testing solutions provider Quidel has opened a new manufacturing facility for the mass production of QuickVue rapid antigen tests for Covid-19. The 128,000ft² facility, which is claimed
The US Food and Drug Administration (FDA) has granted an emergency use authorisation (EUA) for a new Covid-19 antibody test developed by the University of Denver. The University of
Health technology company Royal Philips has introduced a new image-guided therapy solution, called ClarifEye Augmented Reality Surgical Navigation, for spine procedures. The new solution has been designed to
Medical devices maker Inovytec has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its Ventway Sparrow line of ventilators. The ventilators, which are already
CooperSurgical, a wholly-owned subsidiary of CooperCompanies, has acquired US-based AEGEA Medical for an undisclosed sum. Based in California, AEGEA Medical manufactures Mara water vapour ablation system, which is
AdaptHealth has completed the acquisition of technology-enabled respiratory and home medical equipment (HME) distribution platform AeroCare Holdings. The transaction amount includes around $1.1bn and 31 million shares of